Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004345 · ClinicalTrials.gov registry record
Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Terminated
- Registry status
- 100
- Enrollment target
NCT00004345 is a clinical trial that was terminated before completion, run by National Center for Research Resources (NCRR). The registered enrollment target is 100 participants.
The verdict
NCT00004345 was terminated before completion, sponsored by National Center for Research Resources (NCRR).
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Examine the concentration of docosahexanoic acid (DHA) and other n-3 fatty acids in plasma, erythrocyte, and adipose tissue in patients with various forms of retinitis pigmentosa and Usher syndrome. II. Determine the synthesis and catabolism of DHA from linolenic acid in these patients. III. Determine the synthesis, absorption, and catabolism of DHA under different dietary conditions in these patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 1999-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004345
The ClinicalTrials.gov registry entry for NCT00004345 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00004345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004345 about?
NCT00004345 is a clinical study titled "Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome". OBJECTIVES: I. Examine the concentration of docosahexanoic acid (DHA) and other n-3 fatty acids in plasma, erythrocyte, and adipose tissue in patients with various forms of retinitis pigmentosa and Usher syndrome. II. Determine the synthesis and catabolism of DHA from linolenic acid in these patien...
What is the current status of trial NCT00004345?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 1999-10.
Who is sponsoring clinical trial NCT00004345?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.